table of content
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Diagnostics and Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Diagnostics and Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Diagnostics and Therapy Overall Market Size
2.1 Global Prostate Cancer Diagnostics and Therapy Market Size: 2022 VS 2029
2.2 Global Prostate Cancer Diagnostics and Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Diagnostics and Therapy Players in Global Market
3.2 Top Global Prostate Cancer Diagnostics and Therapy Companies Ranked by Revenue
3.3 Global Prostate Cancer Diagnostics and Therapy Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Diagnostics and Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prostate Cancer Diagnostics and Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Diagnostics and Therapy Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Diagnostics and Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics and Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Diagnostics and Therapy Market Size Markets, 2022 & 2029
4.1.2 Androgen Receptor-Directed Therapy
4.1.3 Taxane-Based Chemotherapy
4.2 By Type - Global Prostate Cancer Diagnostics and Therapy Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Diagnostics and Therapy Revenue, 2018-2023
4.2.2 By Type - Global Prostate Cancer Diagnostics and Therapy Revenue, 2024-2029
4.2.3 By Type - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Diagnostics and Therapy Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Prostate Cancer Diagnostics and Therapy Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Diagnostics and Therapy Revenue, 2018-2023
5.2.2 By Application - Global Prostate Cancer Diagnostics and Therapy Revenue, 2024-2029
5.2.3 By Application - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Prostate Cancer Diagnostics and Therapy Market Size, 2022 & 2029
6.2 By Region - Global Prostate Cancer Diagnostics and Therapy Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Diagnostics and Therapy Revenue, 2018-2023
6.2.2 By Region - Global Prostate Cancer Diagnostics and Therapy Revenue, 2024-2029
6.2.3 By Region - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Prostate Cancer Diagnostics and Therapy Revenue, 2018-2029
6.3.2 US Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.3.3 Canada Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.3.4 Mexico Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Diagnostics and Therapy Revenue, 2018-2029
6.4.2 Germany Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.4.3 France Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.4.4 U.K. Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.4.5 Italy Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.4.6 Russia Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.4.8 Benelux Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Diagnostics and Therapy Revenue, 2018-2029
6.5.2 China Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.5.3 Japan Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.5.4 South Korea Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.5.6 India Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Prostate Cancer Diagnostics and Therapy Revenue, 2018-2029
6.6.2 Brazil Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.6.3 Argentina Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Diagnostics and Therapy Revenue, 2018-2029
6.7.2 Turkey Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.7.3 Israel Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
6.7.5 UAE Prostate Cancer Diagnostics and Therapy Market Size, 2018-2029
7 Prostate Cancer Diagnostics and Therapy Companies Profiles
7.1 Ipsen SA
7.1.1 Ipsen SA Company Summary
7.1.2 Ipsen SA Business Overview
7.1.3 Ipsen SA Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.1.4 Ipsen SA Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.1.5 Ipsen SA Key News & Latest Developments
7.2 Pfizer Inc.
7.2.1 Pfizer Inc. Company Summary
7.2.2 Pfizer Inc. Business Overview
7.2.3 Pfizer Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.2.4 Pfizer Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.2.5 Pfizer Inc. Key News & Latest Developments
7.3 Johnson & Johnson Services Inc.
7.3.1 Johnson & Johnson Services Inc. Company Summary
7.3.2 Johnson & Johnson Services Inc. Business Overview
7.3.3 Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.3.4 Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Services Inc. Key News & Latest Developments
7.4 Bayer AG
7.4.1 Bayer AG Company Summary
7.4.2 Bayer AG Business Overview
7.4.3 Bayer AG Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.4.4 Bayer AG Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.4.5 Bayer AG Key News & Latest Developments
7.5 Abbvie Inc.
7.5.1 Abbvie Inc. Company Summary
7.5.2 Abbvie Inc. Business Overview
7.5.3 Abbvie Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.5.4 Abbvie Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.5.5 Abbvie Inc. Key News & Latest Developments
7.6 Merck & Co. Inc.
7.6.1 Merck & Co. Inc. Company Summary
7.6.2 Merck & Co. Inc. Business Overview
7.6.3 Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.6.4 Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.6.5 Merck & Co. Inc. Key News & Latest Developments
7.7 AstraZeneca PLC
7.7.1 AstraZeneca PLC Company Summary
7.7.2 AstraZeneca PLC Business Overview
7.7.3 AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.7.4 AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.7.5 AstraZeneca PLC Key News & Latest Developments
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Company Summary
7.8.2 Thermo Fisher Scientific Business Overview
7.8.3 Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.8.4 Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.8.5 Thermo Fisher Scientific Key News & Latest Developments
7.9 Dendreon Pharmaceuticals LLC
7.9.1 Dendreon Pharmaceuticals LLC Company Summary
7.9.2 Dendreon Pharmaceuticals LLC Business Overview
7.9.3 Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.9.4 Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.9.5 Dendreon Pharmaceuticals LLC Key News & Latest Developments
7.10 F. Hoffmann-La Roche Ltd
7.10.1 F. Hoffmann-La Roche Ltd Company Summary
7.10.2 F. Hoffmann-La Roche Ltd Business Overview
7.10.3 F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.10.4 F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.10.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.11 Hologic Inc.
7.11.1 Hologic Inc. Company Summary
7.11.2 Hologic Inc. Business Overview
7.11.3 Hologic Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.11.4 Hologic Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.11.5 Hologic Inc. Key News & Latest Developments
7.12 Astellas Pharma Inc.
7.12.1 Astellas Pharma Inc. Company Summary
7.12.2 Astellas Pharma Inc. Business Overview
7.12.3 Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.12.4 Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.12.5 Astellas Pharma Inc. Key News & Latest Developments
7.13 Koninklijke Philips NV
7.13.1 Koninklijke Philips NV Company Summary
7.13.2 Koninklijke Philips NV Business Overview
7.13.3 Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.13.4 Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.13.5 Koninklijke Philips NV Key News & Latest Developments
7.14 Sanofi-Aventis
7.14.1 Sanofi-Aventis Company Summary
7.14.2 Sanofi-Aventis Business Overview
7.14.3 Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.14.4 Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.14.5 Sanofi-Aventis Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
